vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.
ZIPRECRUITER, INC. is the larger business by last-quarter revenue ($111.7M vs $62.1M, roughly 1.8× Cytek Biosciences, Inc.). ZIPRECRUITER, INC. runs the higher net margin — -0.7% vs -70.9%, a 70.2% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 0.6%). ZIPRECRUITER, INC. produced more free cash flow last quarter ($7.6M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -4.4%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
ZipRecruiter, Inc. is an American employment marketplace for job seekers and employers.
CTKB vs ZIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $111.7M |
| Net Profit | $-44.1M | $-835.0K |
| Gross Margin | 52.9% | 89.1% |
| Operating Margin | -9.0% | 3.6% |
| Net Margin | -70.9% | -0.7% |
| Revenue YoY | 8.1% | 0.6% |
| Net Profit YoY | -557.1% | 92.3% |
| EPS (diluted) | — | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $111.7M | ||
| Q3 25 | $52.3M | $115.0M | ||
| Q2 25 | $45.6M | $112.2M | ||
| Q1 25 | $41.5M | $110.1M | ||
| Q4 24 | $57.5M | $111.0M | ||
| Q3 24 | $51.5M | $117.1M | ||
| Q2 24 | $46.6M | $123.7M | ||
| Q1 24 | $44.9M | $122.2M |
| Q4 25 | $-44.1M | $-835.0K | ||
| Q3 25 | $-5.5M | $-9.8M | ||
| Q2 25 | $-5.6M | $-9.5M | ||
| Q1 25 | $-11.4M | $-12.8M | ||
| Q4 24 | $9.6M | $-10.8M | ||
| Q3 24 | $941.0K | $-2.6M | ||
| Q2 24 | $-10.4M | $7.0M | ||
| Q1 24 | $-6.2M | $-6.5M |
| Q4 25 | 52.9% | 89.1% | ||
| Q3 25 | 52.7% | 89.1% | ||
| Q2 25 | 52.3% | 89.3% | ||
| Q1 25 | 48.6% | 89.4% | ||
| Q4 24 | 58.5% | 89.6% | ||
| Q3 24 | 56.3% | 89.4% | ||
| Q2 24 | 54.6% | 89.5% | ||
| Q1 24 | 51.3% | 89.1% |
| Q4 25 | -9.0% | 3.6% | ||
| Q3 25 | -17.6% | -4.4% | ||
| Q2 25 | -23.3% | -5.9% | ||
| Q1 25 | -36.1% | -10.6% | ||
| Q4 24 | 5.2% | -3.6% | ||
| Q3 24 | -8.2% | -2.8% | ||
| Q2 24 | -18.3% | 7.6% | ||
| Q1 24 | -23.9% | -0.7% |
| Q4 25 | -70.9% | -0.7% | ||
| Q3 25 | -10.5% | -8.5% | ||
| Q2 25 | -12.2% | -8.5% | ||
| Q1 25 | -27.5% | -11.7% | ||
| Q4 24 | 16.8% | -9.7% | ||
| Q3 24 | 1.8% | -2.2% | ||
| Q2 24 | -22.4% | 5.7% | ||
| Q1 24 | -13.8% | -5.3% |
| Q4 25 | — | $-0.03 | ||
| Q3 25 | — | $-0.11 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | — | $-0.13 | ||
| Q4 24 | — | $-0.10 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $188.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-77.2M |
| Total Assets | $461.5M | $569.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $188.0M | ||
| Q3 25 | $93.3M | $211.8M | ||
| Q2 25 | $75.5M | $203.5M | ||
| Q1 25 | $95.3M | $221.1M | ||
| Q4 24 | $98.7M | $218.4M | ||
| Q3 24 | $162.3M | $225.6M | ||
| Q2 24 | $177.9M | $271.7M | ||
| Q1 24 | $168.8M | $282.5M |
| Q4 25 | $341.7M | $-77.2M | ||
| Q3 25 | $378.6M | $-76.1M | ||
| Q2 25 | $377.6M | $-65.9M | ||
| Q1 25 | $379.6M | $-11.3M | ||
| Q4 24 | $395.7M | $13.4M | ||
| Q3 24 | $385.5M | $13.6M | ||
| Q2 24 | $389.1M | $24.4M | ||
| Q1 24 | $392.6M | $12.7M |
| Q4 25 | $461.5M | $569.7M | ||
| Q3 25 | $494.9M | $573.6M | ||
| Q2 25 | $493.3M | $592.4M | ||
| Q1 25 | $482.6M | $629.4M | ||
| Q4 24 | $499.5M | $664.1M | ||
| Q3 24 | $491.2M | $652.0M | ||
| Q2 24 | $483.7M | $665.3M | ||
| Q1 24 | $492.1M | $662.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $7.7M |
| Free Cash FlowOCF − Capex | $-1.8M | $7.6M |
| FCF MarginFCF / Revenue | -2.9% | 6.8% |
| Capex IntensityCapex / Revenue | 1.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $7.7M | ||
| Q3 25 | $-3.9M | $2.6M | ||
| Q2 25 | $108.0K | $10.5M | ||
| Q1 25 | $-125.0K | $-9.9M | ||
| Q4 24 | $2.0M | $12.5M | ||
| Q3 24 | $13.2M | $9.3M | ||
| Q2 24 | $6.2M | $21.9M | ||
| Q1 24 | $4.0M | $2.0M |
| Q4 25 | $-1.8M | $7.6M | ||
| Q3 25 | $-4.6M | $2.2M | ||
| Q2 25 | $-1.5M | $10.2M | ||
| Q1 25 | $-974.0K | $-10.2M | ||
| Q4 24 | $1.1M | $12.0M | ||
| Q3 24 | $12.2M | $9.2M | ||
| Q2 24 | $5.2M | $21.7M | ||
| Q1 24 | $3.4M | $1.9M |
| Q4 25 | -2.9% | 6.8% | ||
| Q3 25 | -8.7% | 1.9% | ||
| Q2 25 | -3.2% | 9.1% | ||
| Q1 25 | -2.3% | -9.3% | ||
| Q4 24 | 1.9% | 10.8% | ||
| Q3 24 | 23.7% | 7.8% | ||
| Q2 24 | 11.0% | 17.6% | ||
| Q1 24 | 7.6% | 1.6% |
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 1.3% | 0.3% | ||
| Q2 25 | 3.5% | 0.3% | ||
| Q1 25 | 2.0% | 0.3% | ||
| Q4 24 | 1.6% | 0.4% | ||
| Q3 24 | 2.0% | 0.2% | ||
| Q2 24 | 2.3% | 0.1% | ||
| Q1 24 | 1.3% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 3.12× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
ZIP
| License | $84.3M | 75% |
| Services | $27.4M | 25% |
